Koers Apyx Medical Corporation
Aandelen
APYX
US03837C1062
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,48 USD | -1,33% | +7,25% | -43,51% |
05/04 | Archon Capital Management gaat in gesprek met Apyx Medical Corporation | CI |
01/04 | Stavros G. Vizirgianakis in gesprek met Apyx Medical Corporation | CI |
Omzet 2024 * | 49,94 mln. 46,54 mln. | Omzet 2025 * | 54,52 mln. 50,81 mln. | Marktkapitalisatie | 51,27 mln. 47,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -27 mln. -25,16 mln. | Nettowinst (verlies) 2025 * | -25 mln. -23,3 mln. | EV/omzet 2024 * | 1,03 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,94 x |
K/w-verhouding 2024 * |
-1,9
x | K/w-verhouding 2025 * |
-2,13
x | Werknemers | 252 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,08% |
Recentste transcriptie over Apyx Medical Corporation
1 dag | -1,33% | ||
1 week | +7,25% | ||
Lopende maand | +8,82% | ||
1 maand | +16,54% | ||
3 maanden | -35,37% | ||
6 maanden | -38,33% | ||
Lopend jaar | -43,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15-12-17 |
Andrew Makrides
FOU | Founder | 82 | 01-01-78 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 01-01-78 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 15-03-11 |
Craig Swandal
BRD | Director/Board Member | 63 | 09-03-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,48 | -1,33% | 68 488 |
24-04-24 | 1,5 | +13,64% | 187 605 |
23-04-24 | 1,32 | +4,76% | 54 670 |
22-04-24 | 1,26 | -4,55% | 77 365 |
19-04-24 | 1,32 | -4,35% | 56 886 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-43,51% | 51,27 mln. | |
-2,92% | 185 mld. | |
-3,80% | 105 mld. | |
-5,48% | 66,59 mld. | |
+11,22% | 54,66 mld. | |
+16,74% | 47,78 mld. | |
+4,06% | 41,26 mld. | |
+4,56% | 26,95 mld. | |
+1,64% | 26,37 mld. | |
+12,96% | 24,8 mld. |